The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index

European Journal of Endocrinology

Volumn 153, Issue 2, 2005, Pages 257-264

  Corneli, Ginevra ^b   Di Somma, Carolina ^a   Baldelli, Roberto ^b   Rovere, Silvia ^b   Gasco, Valentina ^b   Croce, Chiara Giulia ^b   Grottoli, Silvia ^b   Maccario, Mauro ^b   Colao, Annamaria ^a   Lombardi, Gaetano ^a   Ghigo, Ezio ^b   Camanni, Franco ^b   Aimaretti, Gianluca ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS HORMONE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

ADULT; ARGININE; BODY MASS INDEX; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 23844482496     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01967     Document Type: Article

References (53)

1. Growth Hormone Research Society, Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
2. Rosen T & Bengtsson B-Å. Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet 1990 336 285-288.
3. Cuneo RC, Salomon F, McGauley GA & Sonksen PH. The growth hormone deficiency syndrome in adults. Clinical Endocrinology 1992 37 387-397.
4. De Boer H, Blok G-J & van der Veen E. Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews 1995 16 63-86.
5. Johannsson G & Bengtsson BA. Growth hormone and the metabolic syndrome. Journal of Endocrinology Investigation 1999 22 41-46.
6. Carroll PV, Christ ER & Sonksen PH. Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge. Trends in Endocrinology and Metabolism 2000 11 231-238.
7. Cook DM, Ludlam WH & Cook MB. The adult growth hormone deficiency syndrome. Advances in Internal Medicine 2000 45 297-315.
8. Jørgensen JOL, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE & Christiansen JS. Beneficial effect of growth hormone treatment in GH-deficient adults. Lancet 1989 i 1221-1225.
9. Salomon F, Cuneo RC, Hesp R & Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 1989 321 1797-1803.
10. Binnerts A, Swart GR, Wilsson JHP, Hoogerbrugge N, Pols HA, Birkenhager JC & Lamberts SW. The effects of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clinical Endocrinology 1992 37 79-87.
11. Abdul Shakoor SK & Shalet SM. Effects of GH replacement on metabolism and physical performance in GH deficient adults. Journal of Endocrinology Investigation 2003 26 911-918.
12. Hoffman DM, O'Sullivan AJ, Baxter RC & Ho KKY. Diagnosis of growth hormone deficiency in adults. Lancet 1994 343 1064-1068.
13. Thorner MO, Bengtsson BA, Ho KKY, Albertsson-Wikland K, Christiansen JS, Faglia G et al. Diagnosis of growth hormone deficiency in adults. Journal of Clinical Endocrinology and Metabolism 1995 80 3097-3098.
14. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E & Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. European Journal of Endocrinology 1996 134 352-356.
15. Shalet SM, Toogood A, Rahim A & Brennan BM. The diagnosis of growth hormone deficiency in children and adults. Endocrine Review 1998 19 203-223.
16. Ghigo E, Aimaretti G, Arvat E & Camanni F. Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine 2001 15 29-38.
17. Abs R. Update on the diagnosis of GH deficiency in adults. European Journal of Endocrinology 2003 148 S3-S8.
18. Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB, Rodbard HW, Seibel JA, Vance ML, Zimmerman D, Palumbo PJ, Bergman DA, Garber JR, Hamilton CR Jr, Petak SM, Rettinger HI, Service FJ, Shanker TP, Stoffer SS & Tourletot JB. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children-2003 update. Endocrine Practice 2003 9 64-76.
19. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A & Rosenfeld RG. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. Journal of Clinical Endocrinology and Metabolism 2001 86 3001-3008.
20. Aimaretti G, Corneli G, Baldelli R, Di Somma C, Gasco V, Durante C, Ausiello L, Rovere S, Grottoli S, Tamburrano G & Ghigo E. Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. Clinical Endocrinology 2003 59 56-61.
21. Aimaretti G, Corneli G, Di Somma C, Baldelli R, Gasco V, Rovere S, Durante C, Migliaretti G, Colao A, Tamburrano C, Lombardi G, Ghigo E & Camanni I. Different degrees of GH deficiency evidenced by GHRH-arginine test and IGF-I levels in adults with pituitary disease. Journal of Endocrinology Investigation 2005 28 247-252.
22. Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM & Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clinical Endocrinology 1994 41 123-128.
23. Hoeck HC, Vestergoard P, Jakobson PE & Laurberg P. Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. European Journal of Endocrinology 1995 133 305-312.
24. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F & Ghigo E. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. Journal of Clinical Endocrinology and Metabolism 1998 83 1615-1618.
25. Aimaretti G, Baffoni C, DiVito L, Bellone S, Grottoli S, Maccario M, Arvat E, Camanni F & Ghigo E. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. European Journal of Endocrinology 2000 142 347-352.
26. Kopelman PG, Noonan K, Goulton R & Forrest AJ. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity. Clinical Endocrinology 1985 23 87-94.
27. Ghigo E, Procopio M, Boffano GM, Arvat E, Valente F, Maccario M, Mazza E & Camanni F. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism 1992 41 560-563.
28. Maccario M, Gauna C, Procopio M, Di Vito L, Rossetto R, Oleandri SE, Grottoli S, Ganzaroli C, Aimaretti G & Ghigo E. Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH-arginine test. Journal of Endocrinology Investigation 1999 22 424-429.
29. Maccario M, Valetto MR, Savio P, Aimaretti G, Baffoni C, Procopio M, Grottoli S, Oleandri SE, Arvat E & Ghigo E. Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. International Journal of Obesity and Related Metabolism Disorders 1997 21 27-32.
30. Scacchi M, Pincelli AI & Cavagnini F. Growth hormone in obesity. International Journal of Obesity and Related Metabolism Disorders 1999 23 260-271.
31. Cordido F, Alvarez-Castro P, Isidro ML, Casanueva FF & Dieguez C. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. European Journal of Endocrinology 2003 149 117-122.
32. De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D & Tacchino RM. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition. Journal of Clinical Endocrinology and Metabolism 2004 89 174-180.
33. Bonert VS, Elashoff JD, Barnett P & Melmed S. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 2004 89 3397-3401.
34. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ & Hartman ML. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 2002 87 2067-2079.
35. Zweig MH & Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry 1993 39 561-577.
36. Toogood AA, Beardwell CG & Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clinical Endocrinology 1994 41 511-516.
37. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR & Chipman JJ. HyposCCS Advisory Board; U.S. HypoCCS Study Group. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 2002 87 477-485.
38. Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R & Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. Journal of Neurosurgery 2000 93 743-752.
39. Benvenga S, Campenni A, Ruggeri RM & Trimarchi F. Clinical review 113: Hypopituitarism secondary to head trauma. Journal of Clinical Endocrinology and Metabolism 2000 85 1353-1361.
40. Aimaretti G, Ambrosio MR, Di Somma C, Fusco A, Cannavo S, Gasperi M, Scaroni C, De Marinis L, Benvega S, degli Uberti EC, Lombardi G, Mantero F, Martino E, Giordano G & Ghigo E. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clinical Endocrinology 2004 61 320-326.
41. Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C & Casanueva FF. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 2000 356 1137-1142.
42. Aimaretti G, Bellone S, Baffoni C, Corneli G, Origlia C, Di Vito L, Rovere S, Arvat E, Camanni F & Ghigo E. Short procedure of GHRH plus arginine test in clinical practice. Pituitary 2001 4 129-134.
43. Iranmanesh A, Lizarralde G & Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism 1991 73 1081-1088.
44. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML & Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. Journal of Clinical Endocrinology and Metabolism 1991 72 51-59.
45. Korbonits M & Grossman AB. Ghrelin: update on a novel hormonal system. European Journal of Endocrinology 2004 151 S67-S70.
46. Cordido F, Fernandez T, Martinez T, Penalva A, Peino R, Casanueva FF & Dieguez C. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism. Journal of Clinical Endocrinology and Metabolism 1998 83 4350-4354.
47. Lanzi R, Luzi L, Caumo A, Andreotti AC, Manzoni MF, Malighetti ME, Sereni LP & Pontiroli AE. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects. Metabolism 1999 48 1152-1156.
48. Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C, Thorner MO & Hartman ML. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. Journal of Clinical Endocrinology and Metabolism 2001 86 3845-3852.
49. Reutens AT, Hoffman DM, Leung KC & Ho KK. Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 1995 80 480-485.
50. Bidlingmaier M, Wu Z & Strasburger CJ. Test method: GH. Baillieres in Best Practice Research Clinical Endocrinology and Metabolism 2000 14 99-109.
51. Clemmons DR & Van Wyk JJ. Factors controlling blood concentration of somatomedin C. Journal of Clinical Endocrinology and Metabolism 1984 13 113-143.
52. Copeland KC, Coletti RB, Devlin JT & McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism 1990 39 584-587.
53. Cordido F, Casanueva FF, Vidal JI & Dieguez C. Study of insulin-like growth factor I in human obesity. Hormone Research 1991 36 187-191.